PDF
Word
This version of the form is not currently in use and is provided for reference only. Download this version of
Form HLTH5485
for the current year.
Form HLTH5485 Special Authority Request - Adalimumab for the Treatment of Active Moderate to Severe Hidradenitis Suppurativa - British Columbia, Canada
Form HLTH5485 Special Authority Request - Adalimumab for the Treatment of Active Moderate to Severe Hidradenitis Suppurativa - British Columbia, Canada is a form used in British Columbia, Canada to request special authority for the use of the medication Adalimumab in the treatment of active moderate to severe Hidradenitis Suppurativa.
The form HLTH5485 Special Authority Request - Adalimumab for the Treatment of Active Moderate to Severe Hidradenitis Suppurativa is filed by healthcare providers or physicians in British Columbia, Canada.
FAQ
Q: What is the purpose of the HLTH5485 form?
A: The form is for requesting special authority for Adalimumab treatment for Hidradenitis Suppurativa.
Q: What condition is Adalimumab used to treat?
A: Adalimumab is used to treat active moderate to severe Hidradenitis Suppurativa.
Q: What is Hidradenitis Suppurativa?
A: Hidradenitis Suppurativa is a chronic inflammatory skin condition.
Q: What is special authority?
A: Special authority is a process by which exceptional coverage may be granted for certain medications or treatments.
Download Form HLTH5485 Special Authority Request - Adalimumab for the Treatment of Active Moderate to Severe Hidradenitis Suppurativa - British Columbia, Canada
1
2
